Antiplatelet status of patients in the US WEB-IT Trial
| Visit | Antiplatelet therapy, % (n/N) | ||
| Dual | Single | None | |
| Baseline | 12.7 (19/150) | 14.7 (22/150) | 72.7 (109/150) |
| Procedure | 69.3 (104/150) | 27.3 (41/150) | 3.3 (5/150) |
| 30 Days | 31.3 (47/150) | 56.0 (84/150) | 12.7 (19/150) |
| 6 Months | 11.3 (16/142) | 62.7 (89/142) | 26.1 (37/142) |
| 12 Months | 7.0 (10/143) | 41.3 (59/143) | 51.7 (74/143) |